IP in the Time of COVID-19
COVID-19 has turned nearly every aspect of American life and business upside down. Concern for...
Read Moreby Michael Gallagher | Apr 1, 2020 | Business, News, Patents, Trademarks | 0
COVID-19 has turned nearly every aspect of American life and business upside down. Concern for...
Read Moreby Michael Gallagher | Mar 9, 2020 | Business, Featured Posts, Patents | 0
Ever since the BREXIT process began, IP lawyers, and businesses with European IP interests have...
Read Moreby Michael Gallagher | Oct 16, 2019 | Healthcare & Life Sciences, Litigation, Patents | 0
The Federal Circuit seems to be further confusing the already confused picture on the patenting of...
Read Moreby Michael Gallagher | Oct 10, 2019 | Litigation, Patents | 0
Two Texas judges have come to different conclusions as to whether a refusal to read other parties’...
Read Moreby Michael Gallagher | Sep 9, 2019 | Business, Litigation, Patents | 0
In a case recently decided by the Court of Appeals for the Federal Circuit (CAFC), the appeals court appears to announce procedural requirements that may cut down the usefulness of early dismissal motions under the Supreme Court’s landmark Alice Corporation case.
Read Moreby Michael Gallagher | Jun 3, 2019 | Internet, Litigation, Patent Trial and Appeal Board, Patents | 0
Printed publications disclosing an invention, or an obvious variant, have long served as the basis...
Read Moreby Michael Gallagher | May 8, 2019 | Litigation, Patent Infringement, Patents | 0
Patent infringement has long been subject to a special venue (site of litigation) statute, 28...
Read Moreby Michael Gallagher | May 7, 2019 | Featured Posts, Healthcare & Life Sciences, Litigation, Patent Infringement, Patents | 0
A very complex settlement agreement, with a bit of sloppy drafting, torpedoed a patent...
Read Moreby Michael Gallagher | Apr 30, 2019 | Healthcare & Life Sciences, Litigation, Patents | 0
35 U.S.C. (the patent statute) § 102(b)’s bans the patenting of inventions in “public use” in the...
Read Moreby Michael Gallagher | Apr 20, 2019 | Featured Posts, Healthcare & Life Sciences, Litigation, Patents | 0
A patent for a liquid cannabinoid formulation has survived its first court challenge on the road...
Read Moreby Michael Gallagher | Apr 8, 2019 | Healthcare & Life Sciences, Litigation, News, Patents | 0
The Federal Circuit has ruled two more Cleveland Clinic medical test (or “method”) patents...
Read Moreby Michael Gallagher | Apr 1, 2019 | Litigation, Patents | 0
In 2014, the Supreme Court, in Alice Corporation, Pty., Ltd. v. CLS Bank (read here), ruled that...
Read Moreby Michael Gallagher | Mar 30, 2019 | Patent Trial and Appeal Board, Patents | 0
Anderson Corp., the window manufacturer, could not produce the records needed to sustain a...
Read Moreby Michael Gallagher | Mar 30, 2019 | Healthcare & Life Sciences, News, Patent Infringement, Patent Trial and Appeal Board, Patents | 0
The Patent Trial and Appeal Board has upheld a patent at the center of an infringement suit for a...
Read Moreby Michael Gallagher | Mar 27, 2019 | Litigation, News, Patent Infringement, Patents | 0
An Illinois federal jury awarded $3 million in damages against Nestle Purina in a patent...
Read More